Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ji Wu, Yang Fu, Ying-xing Wu, Zu-xiang Wu, Zhen-hua Wang & Ping Li. (2021) Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis. Bioengineered 12:1, pages 5583-5594.
Read now
Read now
Articles from other publishers (17)
Yin Zhang, Yong-Bo Lu, Wei-Jie Zhu, Xiao-Xi Gong, Rui Qian, Yi-Jing Lu, Yu Li, Wei-Feng Yao, Bei-Hua Bao, Yi Zhang, Li Zhang & Fang-Fang Cheng. (2024) Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway. Journal of Ethnopharmacology 324, pages 117737.
Crossref
Crossref
Xiangyun Li, Shanshan Wei, Sa Liu, Suifen Xie, Jiaqin Liu, Yuanying Yang, Ye Chen, BiKui Zhang, Wenqun Li & Fen Luo. (2024) Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle. Natural Product Communications 19:3.
Crossref
Crossref
Jieru Li, Bochuan Deng, Jiao Zhang, Xiang Zhang, Lu Cheng, Guofeng Li, Ping Su, Xiaokang Miao, Wenle Yang, Junqiu Xie & Rui Wang. (2024)
The Peptide DH
α
-(4-pentenyl)-ANPQIR-NH
2
Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents
. Journal of Pharmacology and Experimental Therapeutics 388:2, pages 701-714.
Crossref
Crossref
Baixi Shan, Haoyan Zhou, Congying Guo, Xiaolu Liu, Mingyu Wu, Rao Zhai & Jun Chen. (2024) Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using 13C metabolic flux analysis. Journal of Pharmaceutical Analysis 14:2, pages 244-258.
Crossref
Crossref
Zheng Zhou, Jingxian Feng, Juncheng Huo, Shi Qiu, Pan Zhang, Yun Wang, Qing Li, Yajing Li, Cuicui Han, Xiaobing Feng, Yonghao Duan, Ruibin Chen, Ying Xiao, Ying He, Lei Zhang & Wansheng Chen. (2024)
Versatile CYP98A enzymes catalyse
meta
‐hydroxylation reveals diversity of salvianolic acids biosynthesis
. Plant Biotechnology Journal.
Crossref
Crossref
Yanwei Hao, Jiaxin Li, Lijuan Dan, Xuanyu Wu, Xiang Xiao, Han Yang, Rui Zhou, Bin Li, Fei Wang & Quanyu Du. (2024) Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms. Journal of Ethnopharmacology 318, pages 116836.
Crossref
Crossref
Yuemei Yan, Dianyu Cao, Jian Liang, Qiaorong Yang, Di Gao, Chen Shen, Feifei Hu, Zheng Li, Yumei Han, Xin Cao & Qiang Wang. (2023) Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin‐Induced Murine Model of Systemic Sclerosis. Advanced Biology 8:1.
Crossref
Crossref
Min Zhang, Jian-Xia Zhou, Chu-Qin Huang, Kang-Ni Feng, Xiao-Ling Zou, Jie-Mei Cen, Ping Meng, Hong-Tao Li & Tian-Tuo Zhang. (2023) IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ. Clinical and Experimental Immunology 214:3, pages 260-274.
Crossref
Crossref
Wei Lei, Chun-yan Chen, Feng-jie Zhou, Yao-lei Ma, Yu-hong Li & Han Zhang. (2023) Tanshinol alleviates ischemia-induced myocardial fibrosis via targeting ERK2 and disturbing the intermolecular autophosphorylation of ERK2Thr188. Biomedicine & Pharmacotherapy 168, pages 115729.
Crossref
Crossref
Jiabin Liang, Lulu Cheng, Jie Feng, Zeping Han, Chen Huang, Fangmei Xie, Yongsheng Li, Xun Luo, Qingmei Wang, Jinhua He & Hanwei Chen. (2023) Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation. BMC Complementary Medicine and Therapies 23:1.
Crossref
Crossref
Qingyin Liu, Xue Liu, Guoyu Wang, Fan Wu, Yuan Hou & Huaman Liu. (2023) Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Shoichiro SaitoMasahiro KitabatakeNoriko Ouji-SageshimaTatsuro Ogawa, Akihisa OdaTomoko NishimuraTatsuki NishiokaSatoki FushimiAtsushi HaraShigeyuki Shichino, Makiko Kumamoto, Shigeto Hontsu, Takeshi Kawaguchi, Satoshi Ueha, Noriyoshi Sawabata, Shigeo Muro, Kouji Matsushima & Toshihiro Ito. (2023) Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development. American Journal of Respiratory Cell and Molecular Biology 69:3, pages 328-339.
Crossref
Crossref
Dandan Liu, Chaoyang Zhang, Jingting Zhang, Guo-Tong Xu & Jingfa Zhang. (2023) Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium. Neurobiology of Disease 185, pages 106250.
Crossref
Crossref
Wentao Jia, Jiaying Yuan, Binbin Cheng & Changquan Ling. (2023) Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine. Cancer Letters 567, pages 216261.
Crossref
Crossref
Yuan Hou, Guoyu Wang, Shuo Han, Huaman Liu & Xinhua Jia. (2023) Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review. Medicine 102:22, pages e33729.
Crossref
Crossref
Jing Liu, Dongyang Gao, Qi Ding, Binbin Zhang, Wenxiang Zhu & Yuanyuan Shi. (2023) Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway. Journal of Ethnopharmacology 309, pages 116305.
Crossref
Crossref
Zhenghua Wu, Mengqi Jia, Wenjuan Zhao, Xucong Huang, Xinyi Yang, Dongxin Chen, Xijier Qiaolongbatu, Xiaojing Li, Jiaqi Wu, Feng Qian, Yuefen Lou & Guorong Fan. (2022) Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification. Journal of Ethnopharmacology 289, pages 115031.
Crossref
Crossref